We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+58.39%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.77B
AUM Growth
+$909M
Cap. Flow
+$51.4M
Cap. Flow %
1.86%
Top 10 Hldgs %
31.68%
Holding
209
New
25
Increased
86
Reduced
78
Closed
18

Top Buys

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$28.4M
2
BL icon
BlackLine
BL
+$24.3M
3
HQY icon
HealthEquity
HQY
+$21.8M
4
WK icon
Workiva
WK
+$18M
5
AXON
Axon Enterprise
AXON
+$16.7M

Top Sells

Rank Stock Value
1
CHGG icon
Chegg
CHGG
+$46.7M
2
PAYC icon
Paycom
PAYC
+$27.2M
3
ENPH icon
Enphase Energy
ENPH
+$17.8M
4
SPSC icon
SPS Commerce
SPSC
+$16.7M
5
PCTY icon
Paylocity
PCTY
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 35.16%
2 Healthcare 18.29%
3 Industrials 13.17%
4 Consumer Discretionary 9.72%
5 Communication Services 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRPL icon
101
Purple Innovation
PRPL
$39.6M
$5.7M 0.21%
+12,671
New +$4M
CEVA icon
102
CEVA Inc
CEVA
$889M
$5.48M 0.2%
146,529
-4,127
-3% -$132K
TCBI icon
103
Texas Capital Bancshares
TCBI
$4.32B
$5.45M 0.2%
176,564
+102,195
+137% +$2.86M
HBIO icon
104
Harvard Bioscience
HBIO
$28.8M
$5.37M 0.19%
173,314
-11,301
-6% -$304K
AUTL
105
Autolus Therapeutics
AUTL
$551M
$5.3M 0.19%
330,747
+29,022
+10% +$322K
LGND icon
106
Ligand Pharmaceuticals
LGND
$6.42B
$5.24M 0.19%
75,145
-5,829
-7% -$370K
KIDS icon
107
OrthoPediatrics
KIDS
$608M
$4.94M 0.18%
112,809
+9,198
+9% +$414K
NMRK icon
108
Newmark Group
NMRK
$2.52B
$4.78M 0.17%
983,689
-354,773
-27% -$1.49M
PRFT
109
DELISTED
Perficient Inc
PRFT
$4.57M 0.17%
127,591
+29,493
+30% +$979K
NGNE icon
110
Neurogene
NGNE
$729M
$4.56M 0.16%
+13,740
New +$3.58M
BLFS icon
111
BioLife Solutions
BLFS
$1.69B
$4.27M 0.15%
261,382
-13,129
-5% -$181K
MTN icon
112
Vail Resorts
MTN
$5.21B
$4.21M 0.15%
23,127
+14,632
+172% +$2.56M
ECPG icon
113
Encore Capital Group
ECPG
$2.01B
$4.07M 0.15%
118,995
+56,352
+90% +$1.68M
KIN
114
DELISTED
Kindred Biosciences, Inc.
KIN
$4M 0.14%
891,541
-29,052
-3% -$130K
IPHI
115
DELISTED
INPHI CORPORATION
IPHI
$3.9M 0.14%
33,234
-7,023
-17% -$739K
NTNX icon
116
Nutanix
NTNX
$17.4B
$3.83M 0.14%
161,732
+42,262
+35% +$875K
QLYS icon
117
Qualys
QLYS
$6.43B
$3.77M 0.14%
36,230
-4,930
-12% -$517K
WNS
118
DELISTED
WNS Holdings
WNS
$3.76M 0.14%
68,410
+13,222
+24% +$631K
KNSL icon
119
Kinsale Capital Group
KNSL
$8.4B
$3.68M 0.13%
23,709
-9,887
-29% -$1.32M
LQDT icon
120
Liquidity Services
LQDT
$1.28B
$3.57M 0.13%
598,264
+69,050
+13% +$366K
PRTK
121
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.57M 0.13%
683,103
-19,629
-3% -$87.2K
JNCE
122
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.56M 0.13%
515,748
+251,609
+95% +$1.36M
TTGT icon
123
TechTarget
TTGT
$282M
$3.49M 0.13%
116,329
-7,390
-6% -$186K
STNG icon
124
Scorpio Tankers
STNG
$3.83B
$3.41M 0.12%
266,289
+56,105
+27% +$1.02M
VRNS icon
125
Varonis Systems
VRNS
$4.87B
$3.38M 0.12%
114,519
+62,898
+122% +$1.57M

Similar funds

Granahan Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Granahan Investment Management held 209 positions worth $2.77B, up 49% from $1.86B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Granahan Investment Management's Q2 2020 filing shows 25 new, 86 increased, 78 reduced and 18 closed positions. Its largest new stake was BlackLine: 364,676 shares worth $30.2M. The largest sale was Chegg, an estimated $46.7M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q2 2020 buy was BlackLine: 364,676 shares worth $30.2M.
  • Granahan Investment Management added most to Magnite in Q2 2020, an estimated $28.4M increase.
  • Granahan Investment Management's biggest Q2 2020 reduction was Chegg, cutting an estimated $46.7M.
  • Granahan Investment Management fully exited The Ensign Group in Q2 2020, selling an estimated $14M.
  • Granahan Investment Management's ten largest holdings make up 32% of its $2.77B portfolio in Q2 2020.
  • Granahan Investment Management opened 25 new positions and closed 18 in Q2 2020.
  • Granahan Investment Management's portfolio value rose 49% quarter-over-quarter to $2.77B.

Based on Granahan Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.